Company Filing History:
Years Active: 2019
Title: **Bengt Staffan Schantz: Innovating in Polyunsaturated Fatty Acid Formulations**
Introduction
Bengt Staffan Schantz is an innovative inventor based in Mölndal, Sweden, known for his significant contributions to the field of pharmaceuticals, particularly in the formulation of polyunsaturated fatty acids (PUFAs). With a keen focus on enhancing medication delivery, Schantz's work has paved the way for advanced capsular dosage forms that have potential therapeutic advantages.
Latest Patents
Schantz holds a notable patent titled "Millicapsule formulations comprising polyunsaturated free fatty acids." This patent introduces capsular dosage forms that contain PUFA compositions, specifically designed to improve the absorption and effectiveness of these vital fatty acids in medical applications. The innovation encompasses various embodiments, including unit dosage forms featuring multiple millicapsules, which offer substantial benefits in patient treatment through the encapsulation of PUFAs in their free acid form. One such composition referenced within the patent is Epanova®, further showcasing the practical application of his invention.
Career Highlights
Currently, Schantz is affiliated with Omthera Pharmaceuticals Inc., where he utilizes his expertise to develop cutting-edge pharmaceutical solutions. His career is marked by a dedicated commitment to advancing drug formulation technologies, particularly for lipophilic compounds. His singular patent reflects a targeted approach to optimizing PUFA therapies, which are crucial for various health conditions.
Collaborations
Throughout his career, Schantz has collaborated with notable figures in the industry, including Hironori Kubota and Etienne Thierry Charles Rogeau. These partnerships have facilitated a rich exchange of ideas and advancements, contributing to the innovative processes at Omthera Pharmaceuticals Inc. Together, they have worked on refining formulations that enhance drug delivery and efficacy for patients.
Conclusion
Bengt Staffan Schantz's contributions to the field of pharmaceutical innovation, particularly in the development of millicapsule formulations for polyunsaturated fatty acids, highlight his role as a forward-thinking inventor. His achievements reflect not only his dedication to improving healthcare but also the collaborative spirit within the industry that drives scientific advancements. As he continues his work at Omthera Pharmaceuticals Inc., the future looks promising for further innovations in this vital area of medicine.